Company Filing History:
Years Active: 2025
Title: Jan Ungewiss: Innovator in Fibroblast Activation Protein Research
Introduction
Jan Ungewiss is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of compounds that target fibroblast activation proteins. His innovative work has the potential to impact various therapeutic applications.
Latest Patents
Jan Ungewiss holds a patent for a compound comprising a fibroblast activation protein ligand and its use. The patent describes a compound that includes a cyclic peptide and a chelator, showcasing his expertise in creating novel therapeutic agents.
Career Highlights
Jan is currently associated with 3B Pharmaceuticals GmbH, where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry.
Collaborations
Jan collaborates with talented professionals in his field, including Frank Osterkamp and Dirk Zboralski. These partnerships enhance the research and development process, fostering a collaborative environment for innovation.
Conclusion
Jan Ungewiss is a dedicated inventor whose work in fibroblast activation protein research exemplifies the spirit of innovation in the pharmaceutical industry. His contributions are paving the way for future advancements in therapeutic applications.